´óÏóÊÓƵ

Bytes Technology could benefit from Microsoft’s AI push

The IT reseller suffered due to a change in its relationship with the US software giant, but could now be in value territory

Intertek halts strategic review and backs £10bn takeover

The board has relented to Swedish private equity giant EQT’s latest approach after rejecting three previous bids

Can Novo Nordisk close the gap to Eli Lilly?

The Danish drugmaker’s weight-loss pill is in high demand, but the financial mismatch between the rivals remains stark

Will Herald’s Saba truce work for shareholders?

The trust has struck a deal with the activist investor, which will see Aberdeen become the investment manager 

LondonMetric and Schroder Reit buy Picton’s portfolio

The £400mn deal will see shareholders handed stakes in both Reits

Can Seraphim Space keep up its winning streak?

Recent success means new ´óÏóÊÓƵ face a hefty premium to buy into its early-stage companies

These once AI ‘laggards’ are now popular with ´óÏóÊÓƵ

Intel and Arm shares are surging as they start to benefit from the investment boom

Supply chain chaos creates chemical winners and losers

Hormuz closure looked like a disaster for chemical stocks. Two months on, things appear more positive

Why distributor stocks face a double squeeze on margins

The sector is caught in a tug of war between rising costs and competition from China

The resilient construction stocks still worth investor attention

A slew of positive updates show some companies are in good shape despite choppy markets and weaker share prices